Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tucker

Showing results (471-480 of 549) with videos related to

Pageof 55
Sort By:
Journal of Registry Management|June 1, 2023
Population-Based Cancer Survival in Canada and the United States by Socioeconomic Status: Findings from the CONCORD-2 StudyHannah K Weir, Heather Bryant, Donna Turner, et al.
Journal of Virology|May 1, 1996
Developmental analysis of the cytomegalovirus enhancer in transgenic animalsJ F Baskar, P P Smith, G S Ciment, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|February 13, 2001
From peptide libraries to optimized nonpeptide ligands in the search for S-farnesyltransferase inhibitorsJ M Henlin, J A Boutin, N Kucharczyk, et al.
Cancer Metastasis Reviews|July 8, 2021
Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new challenge for internists and general practitionersMarek Z Wojtukiewicz, Magdalena M Rek, Kamil Karpowicz, et al.
Bioorganic & Medicinal Chemistry|June 24, 2003
Parallel liquid synthesis of N,N'-Disubstituted 3-amino azepin-2-ones as potent and specific farnesyl transferase inhibitorsThierry Le Diguarher, Jean Claude Ortuno, Gilbert Dorey, et al.
Advances in Nutrition (Bethesda, Md.)|December 5, 2019
Carotenoid Intake and Circulating Carotenoids Are Inversely Associated with the Risk of Bladder Cancer: A Dose-Response Meta-analysisShenghui Wu, Yanning Liu, Joel E Michalek, et al.
Transplantation|July 26, 2000
Transplantation of the bone marrow microenvironment leads to hematopoietic chimerism without cytoreductive conditioningA W Bingaman, S Y Waitze, D Z Alexander, et al.
Preventive Medicine|August 3, 2017
Surveillance of high-grade cervical cancer precursors (CIN III/AIS) in four population-based cancer registries, United States, 2009-2012Meg Watson, Ashwini Soman, Elaine W Flagg, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Synthesis of N,N'-disubstituted 3-aminobenzo[c] and [d]azepin-2-ones as potent and specific farnesyl transferase inhibitorsThierry Le Diguarher, Jean-Claude Ortuno, David Shanks, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1980
Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humansR J Whitley, B C Tucker, A W Kinkel, et al.
Pageof 55

Showing results (471-480 of 549) with videos related to

Sort By:
Pageof 55
Journal of Registry Management|June 1, 2023
Population-Based Cancer Survival in Canada and the United States by Socioeconomic Status: Findings from the CONCORD-2 StudyHannah K Weir, Heather Bryant, Donna Turner, et al.
Journal of Virology|May 1, 1996
Developmental analysis of the cytomegalovirus enhancer in transgenic animalsJ F Baskar, P P Smith, G S Ciment, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|February 13, 2001
From peptide libraries to optimized nonpeptide ligands in the search for S-farnesyltransferase inhibitorsJ M Henlin, J A Boutin, N Kucharczyk, et al.
Cancer Metastasis Reviews|July 8, 2021
Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new challenge for internists and general practitionersMarek Z Wojtukiewicz, Magdalena M Rek, Kamil Karpowicz, et al.
Bioorganic & Medicinal Chemistry|June 24, 2003
Parallel liquid synthesis of N,N'-Disubstituted 3-amino azepin-2-ones as potent and specific farnesyl transferase inhibitorsThierry Le Diguarher, Jean Claude Ortuno, Gilbert Dorey, et al.
Advances in Nutrition (Bethesda, Md.)|December 5, 2019
Carotenoid Intake and Circulating Carotenoids Are Inversely Associated with the Risk of Bladder Cancer: A Dose-Response Meta-analysisShenghui Wu, Yanning Liu, Joel E Michalek, et al.
Transplantation|July 26, 2000
Transplantation of the bone marrow microenvironment leads to hematopoietic chimerism without cytoreductive conditioningA W Bingaman, S Y Waitze, D Z Alexander, et al.
Preventive Medicine|August 3, 2017
Surveillance of high-grade cervical cancer precursors (CIN III/AIS) in four population-based cancer registries, United States, 2009-2012Meg Watson, Ashwini Soman, Elaine W Flagg, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Synthesis of N,N'-disubstituted 3-aminobenzo[c] and [d]azepin-2-ones as potent and specific farnesyl transferase inhibitorsThierry Le Diguarher, Jean-Claude Ortuno, David Shanks, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1980
Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humansR J Whitley, B C Tucker, A W Kinkel, et al.
Pageof 55